TANZISERTIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H23F3N6O2
Molecular Weight	448.4415
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of TANZISERTIB

Structure Search

SMILES

[H][C@@]1(CCOC1)N2C(NC3=C(F)C=C(F)C=C3F)=NC4=CN=C(N[C@H]5CC[C@H](O)CC5)N=C24

InChI

InChIKey=IBGLGMOPHJQDJB-IHRRRGAJSA-N

InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12-,13-,14-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C21H23F3N6O2
Molecular Weight	448.4415
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:53:29 UTC 2023` Edited by `admin` on `Fri Dec 15 16:53:29 UTC 2023`
Record UNII	M5O06306UO
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TANZISERTIB

Official Name

English

tanzisertib [INN]

Common Name

English

TRANS-4-((9-((3S)-TETRAHYDROFURAN-3-YL)-8-((2,4,6-TRIFLUOROPHENYL)AMINO)-9H-PURIN-2- YL)AMINO)CYCLOHEXANOL

Systematic Name

English

JNK930

Code

English

JNK-930

Code

English

TANZISERTIB [USAN]

Common Name

English

CC-930

Code

English

CYCLOHEXANOL, 4-((9-((3S)-TETRAHYDRO-3-FURANYL)-8-((2,4,6-TRIFLUOROPHENYL)AMINO)-9H-PURIN-2-YL)AMINO)-, TRANS-

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

348911

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

NCI_THESAURUS

C1404

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

Code System Code Type Description

NCI_THESAURUS

C152510

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

ChEMBL

CHEMBL1950289

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

USAN

YY-12

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

SMS_ID

100000181869

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

INN

9557

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

DRUG BANK

DB11798

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

PUBCHEM

11597537

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

EPA CompTox

DTXSID901026042

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

FDA UNII

M5O06306UO

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

CAS

899805-25-5

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

EU-Orphan Drug

EU/3/11/934(POSITIVE)

Created by admin on Fri Dec 15 16:53:29 UTC 2023 , Edited by admin on Fri Dec 15 16:53:29 UTC 2023

PRIMARY

Treatment of idiopathic pulmonary fibrosis 9/12/2011 Positive

Related Record Type Details


					M7UO4Z8IZ3

MITOGEN-ACTIVATED PROTEIN KINASE 9

TARGET -> INHIBITOR

Amount:


					B2BR0KE2T8

MITOGEN-ACTIVATED PROTEIN KINASE 8

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					M5O06306UO

ACTIVE MOIETY

Amount: